radiation

MD Anderson Made the Case for Radiation Cleanup After Immunotherapy. Then Its Own Trial Undercut It.

In the oligometastatic subgroup the strategy was built for, small and underpowered, the patients who added radiation trended the wrong way: median survival of 42 months against 75.8 for the drugs alone.